Current Size: 100%

News

LBG Meeting for Health Sciences 2018

Call for Abstracts ends on September, 10th - Submit your abstract now

The Ludwig Boltzmann Gesellschaft invites interested scientists for this year’s LBG Meeting on Health Sciences from 29.-30. November 2018.
The meeting encourages and supports early career researchers to establish themselves within the scientific field. The conference focuses on the translation of research results from theory into practice. The thematic sessions will include keynote lectures by international experts and oral presentations of the best submitted abstracts.

Nature Immunology study by LBI-RUD researchers on novel rare immunodeficiency

A hitherto unknown gene mutation revealed the role of a key molecule for immune cell development. The international team led by LBI-RUD director Kaan Boztug gained fundamentally new insights into the human immune system by studying this newly discovered mutation. Moreover, their research revealed a potential personalized therapy for this rare disease. The study, published in Nature Immunology, clearly highlights the importance and opportunities of research in the field of rare diseases.

WWTF Precision Medicine Grant for LBI-RUD Researchers

LBI-RUD director Kaan Boztug, together with Loïc Dupré (LBI-RUD) and Jörg Menche (CeMM) won one out of five prestigious research grants by the Vienna Science and Technology Fund (WWTF) in their 2016 Life Science Precision Medicine Call, granted for their innovative research project that has the potential to significantly contribute to major advancements in the field of personalized medicine and treatment options. The funding amounts to a total of nearly 1 Mio. EUR for three years.

WWTF Precision Medicine Grant for LBI-RUD Researchers

LBI-RUD director Kaan Boztug, together with Loïc Dupré (LBI-RUD) and Jörg Menche (CeMM) won one out of five prestigious research grants by the Vienna Science and Technology Fund (WWTF) in their 2016 Life Science Precision Medicine Call, granted for their innovative research project that has the potential to significantly contribute to major advancements in the field of personalized medicine and treatment options. The funding amounts to a total of nearly 1 Mio. EUR for three years.